BCAL Diagnostics Limited Price (BDX.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

246,225,497

(16.7484)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is h... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.086-0.185
  • Market Cap 35.13M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

  • ceo: Mr. Shane Ryan M.B.A.
  • IPO Date: July, 21, 2021
  • Country: AU
  • Currency: AUD
  • Headquaters: Sydney, NSW
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation